Indraprastha Medical Corporation Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
INDRAMEDCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.8 pts more than Nifty Microcap 250 and 4.6 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Indraprastha Medical Corporation (Indraprastha Apollo Hospitals) reported unaudited results for Q1 FY26 (quarter ended 30 June 2025). Revenue from operations rose about 5% year-on-year to Rs 365.06 crore, up from Rs 347.86 crore in Q1 FY25. Profit before tax grew nearly 15% to Rs 68.31 crore, and profit after tax climbed to Rs 51.46 crore from Rs 44.77 crore, with basic EPS of Rs 5.61 versus Rs 4.88. Total expenses rose only marginally to Rs 303.65 crore, showing cost discipline. The auditor (S.N. Dhawan & Co LLP) issued a clean limited review report with no qualifications. The Board also appointed Mr. Sudhir Jalan as Independent Director for 5 years, re-appointed cost auditors, appointed M/s RSM & Co. as secretarial auditors, and fixed 18 September 2025 as the record date for the FY25 dividend with the AGM scheduled for 24 September 2025.
Steady operational performance with mid-teens profit growth on modest revenue expansion signals stable hospital demand. The dividend record date means shares bought before 18 September 2025 will qualify for the FY25 dividend, which is a near-term positive for shareholders.